2p interim dividend. |
Surely another placing coming with the shares at this level |
Post demerger closing high. |
Results next thursday. |
I've now switched over to Haleon's Aquafresh toothpaste and Corsodyl Daily mouthwash .
Very good indeed :-) |
Haleon PLC (LSE:HLN, NYSE:HLN) first half/second quarter results on 1 August should be the last of ‘noise and volatility’ this year, suggests broker Jefferies.
From here on, it should be a normalised base of sales says the US bank, which expects volumes and product mix to underline it can be a 4-6% organic growth business.
Second quarter underlying volume is likely to be more than 3%, it adds and is a buyer with a 385p target.
Deutsche Bank has a lower target of 340p for the Sensodyne maker, which was recently reduced down from 345p, and a hold rating based on its current rating relative to the sector.
“If we apply the Colgate forward 12m PE to Oral Care the remainder is on 14x 12-month earnings, which would be too low if cold & flu is strong.
“We see a re-rating as centred on this currently.”
proactiveinvestors.co.uk |
Accelerate debt reduction, hit the net debt/EBITDA ratio target then hike the dividends.. :o) |
Indeed :-)
Haleon sells off nicotine brands for £500m as it trims down its consumer health portfolio |
£500m |
What's that in pounds please! |
Dr. Reddy's To Buy Haleon's Anti-Smoking Aid Portfolio For Rs 5,290 Crore
The transaction is expected to close by early fourth quarter of calendar year 2024, according to an exchange filing.
[...] |
Must be close to 90 days. |
Corsodyl unveils new toothpaste and mouthwash range targeted at preventing gum problems |
My hunch is that it will wait until post the H1 results then do another ABB. |
Pfizer getting ready to sell it's remaining 22% holding ?
This from RNS 21st march 2024
"Following the Global Offer the remaining Pfizer shares in Haleon will be subject to a lock up period of 90 days in favour of Citigroup and Morgan Stanley, subject to customary exceptions and to waiver." |
Welcome! Holding a double weighting. |
Bought a snall amount. |
Just googled ..Eroxon, I see ;. |
 Berenberg note details..
Berenberg initiated coverage of consumer health company Haleon on Wednesday with a 'buy' rating and 407.0p price target, stating that its investment case was based in part on the US launch of Eroxon, which it expects to drive better-than-expected organic sales growth of 5.8% in 2025.
Berenberg said the opportunity from the US launch of Eroxon - the first-ever over-the-counter erectile dysfunction topical cream - was "substantial". It noted that among men of all ages, 20% suffer from ED, but the condition was more pronounced in older age groups, as 50% of over 40s experience ED.
"Importantly, 80% of men who suffer from ED are not taking any treatment, meaning the addressable market for Eroxon is significant," it said. "We conservatively estimate that the US rollout will improve group organic sales by an average of 0.8pp in its first five years (2025-29). We note that there are already encouraging signs from the rollout of Eroxon in the UK and Belgium, with the brand gaining 20% share in its first 12 months."
The bank's investment case was also based on Haleon's exposure to attractive categories that it expects to grow 4.6% in the medium term, above Berenberg's forecast sector average of 4.1%; and the stock trading on a valuation discount of 17% to key household and personal care (HPC) peers. Berenberg also noted that Haleon trades on a 12-month forward price-to-earnings of 17.3x. |
Berenberg starts Haleon with 'buy' - price target 407 pence
Could Pfizer be unloading half it's remaining stake this month ? |
As per RNS
31 May 2024: Haleon plc ("Haleon") has today announced that it has completed the disposal of the ChapStick brand to Suave Brands Company, a portfolio company of Yellow Wood Partners. |
Couldn't get my usual Colgate toothpaste in Sainsbury's this week so I looked for a quick replacement and came away with a tube of Aquafresh. Very good indeed and much cheaper at 80p . And made by HLN :-) |
Indian pharma group readies swoop on anti-smoking aid Nicotinell
Dr Reddy's Laboratories could clinch a deal to buy Nicotinell and a number of other brands from Haleon as soon as this week, Sky News learns. |
Three of my naps from that period either merged or were taken over - Portals, Commercial Union and Wellcome. Happy period. |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
